HIGH

Teva Metoprolol Succinate 200 mg Recall Affects 19,056 Bottles Nationwide (2026)

Teva Pharmaceuticals recalled 19,056 bottles of Metoprolol Succinate Extended-Release Tablets, 200 mg, sold nationwide. The recall cites failed dissolution specifications, which could affect how the drug releases in the body. Patients should stop using the product and contact Teva or their healthcare provider for guidance.

Quick Facts at a Glance

Recall Date
January 29, 2026
Hazard Level
HIGH
Brands
METOPROLOL SUCCINATE, Actavis Pharma
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, ELDERLY

Hazard Information

Failed Dissolution Specifications

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Teva Pharmaceuticals USA, Inc or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Metoprolol succinate extended‑release tablets are a prescription medication distributed nationwide by Teva. The 200 mg strength is formulated for chronic conditions requiring beta‑blocker therapy.

Why This Is Dangerous

Dissolution failures can alter how quickly or how much active drug is released, potentially compromising blood pressure control.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Patients with affected bottles may experience reduced drug effectiveness or blood pressure instability. Clinicians should review patients on the affected NDC.

Practical Guidance

How to identify if yours is affected

  1. Check NDC 45963-678-11 on the bottle label
  2. Inspect lot numbers: 0686H251, 0687H251, 10688H251
  3. Check expiration date: 02/2027
  4. If any match, stop using immediately

Where to find product info

Recall notice lists NDC, lot numbers, and expiration; contact Teva for guidance.

What timeline to expect

Refunds or replacements follow Teva's process; typically 4-8 weeks after eligibility is confirmed.

If the manufacturer is unresponsive

  • Document all communications
  • Consult your healthcare provider for interim guidance
  • File a report with FDA MedWatch if needed

How to prevent similar issues

  • Verify NDC and lot numbers upon receipt of prescriptions
  • Keep medications in original packaging with label intact
  • Watch for recall notices from FDA and manufacturers

Documentation advice

Save recall notices, bottle labels, lot numbers, and all correspondence; photograph bottles and labels for records.

Product Details

- NDC: 45963-678-11\n- Product: Metoprolol Succinate Extended-Release Tablets, 200 mg\n- Bottles per package: 100 tablets\n- Quantity recalled: 19,056 bottles\n- Lot numbers: 0686H251, 0687H251, 10688H251\n- Expiration: 02/2027\n- Brand: METOPROLOL SUCCINATE\n- Manufacturer: Teva Pharmaceuticals USA, Parsippany, NJ\n- Sold nationwide\n- Recall date: 2026-01-29

Key Facts

  • 19,056 bottles recalled
  • NDC 45963-678-11
  • Lot numbers 0686H251, 0687H251, 10688H251
  • Exp 02/2027
  • Distributed nationwide
  • Recall date 2026-01-29

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALELDERLY
Injury Types
OTHER

Product Classification

Product TypeMetoprolol Succinate Extended-Release Tablet
Sold At
Multiple Retailers

Product Details

Model Numbers
0686H251
0687H251
10688H251
UPC Codes
45963-676
45963-709
45963-677
+8 more
Affected States
ALL
Report Date
March 11, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more
Vehicles & Parts
HIGH

Chrysler Pacifica Radio Recall 2025 Over Rearview Camera Display Issue

Chrysler is recalling 2024-2025 Pacifica minivans after a radio installed during production could fail to display the rearview camera image. Dealers will replace the radio at no cost. Owner letters were mailed August 7, 2025. Contact Chrysler customer service at 800-853-1403 for details.

Chrysler
A rearview
Read more